ACA Provisions Associated With Increase In Percentage Of Young Adult Women Initiating And Completing The HPV Vaccine
- PMID: 25941276
- PMCID: PMC7362313
- DOI: 10.1377/hlthaff.2014.1302
ACA Provisions Associated With Increase In Percentage Of Young Adult Women Initiating And Completing The HPV Vaccine
Abstract
Affordable Care Act provisions implemented in 2010 required insurance plans to offer dependent coverage to people ages 19-25 and to provide targeted preventive services with zero cost sharing. These provisions both increased the percentage of young adults with any source of health insurance coverage and improved the generosity of coverage. We examined how these provisions affected use of the human papillomavirus (HPV) vaccine, which is among the most expensive of recommended vaccines, among young adult women. Using 2008-12 data from the National Health Interview Survey, we estimated that the 2010 policy implementation increased the likelihood of HPV vaccine initiation and completion by 7.7 and 5.8 percentage points, respectively, for women ages 19-25 relative to a control group of women age 18 or 26. These estimates translate to approximately 1.1 million young women initiating and 854,000 young women completing the vaccine series.
Keywords: Access To Care; Health Reform; Insurance Coverage < Insurance.
Project HOPE—The People-to-People Health Foundation, Inc.
Figures
Similar articles
-
Associations between insurance-related affordable care act policy changes with HPV vaccine completion.BMC Public Health. 2021 Feb 6;21(1):304. doi: 10.1186/s12889-021-10328-4. BMC Public Health. 2021. PMID: 33549075 Free PMC article.
-
Impact of the Affordable Care Act on human papillomavirus vaccination initiation among lesbian, bisexual, and heterosexual U.S. women.Health Serv Res. 2020 Feb;55(1):18-25. doi: 10.1111/1475-6773.13231. Epub 2019 Nov 10. Health Serv Res. 2020. PMID: 31709542 Free PMC article.
-
The effect of the Affordable Care Act dependent coverage provision on HPV vaccine uptake in young adult women, National Health and Nutrition Examination Survey 2007-2016.Prev Med. 2021 Jul;148:106536. doi: 10.1016/j.ypmed.2021.106536. Epub 2021 Mar 30. Prev Med. 2021. PMID: 33798531
-
Risk Corridors, COVID-19, And The ACA.Health Aff (Millwood). 2020 Jun;39(6):921-922. doi: 10.1377/hlthaff.2020.00693. Epub 2020 May 11. Health Aff (Millwood). 2020. PMID: 32392093 Review.
-
The Affordable Care Act: implications for health-care equity.Lancet. 2017 Apr 8;389(10077):1442-1452. doi: 10.1016/S0140-6736(17)30786-9. Lancet. 2017. PMID: 28402826 Review.
Cited by
-
Impact of supplementary private health insurance on hospitalization and physical examination in China.China Econ Rev. 2020 Oct;63:101514. doi: 10.1016/j.chieco.2020.101514. Epub 2020 Jul 3. China Econ Rev. 2020. PMID: 35058675 Free PMC article.
-
Closing the Gaps: Progress in the Care of Adolescents and Young Adults With Cancer.JCO Oncol Pract. 2021 Jun;17(6):302-304. doi: 10.1200/OP.21.00223. Epub 2021 May 19. JCO Oncol Pract. 2021. PMID: 34010020 Free PMC article. No abstract available.
-
Associations between insurance-related affordable care act policy changes with HPV vaccine completion.BMC Public Health. 2021 Feb 6;21(1):304. doi: 10.1186/s12889-021-10328-4. BMC Public Health. 2021. PMID: 33549075 Free PMC article.
-
Disparities in human papillomavirus (HPV) vaccine initiation and completion based on sexual orientation among women in the United States.Hum Vaccin Immunother. 2021 Feb 1;17(2):428-433. doi: 10.1080/21645515.2020.1778407. Epub 2020 Jul 23. Hum Vaccin Immunother. 2021. PMID: 32701386 Free PMC article.
-
Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018.Cancer Causes Control. 2020 Sep;31(9):839-850. doi: 10.1007/s10552-020-01325-w. Epub 2020 Jun 29. Cancer Causes Control. 2020. PMID: 32602058 Free PMC article.
References
-
- Dunne EF, Unger ER, Sternberg M, McQuillian G, Swan DC, Patel SS, et al., Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–9. - PubMed
-
- Bosch FX, de Sanjosé S. Chapter 1: human papillomavirus and cervical cancer—burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;(31):3–13. - PubMed
-
- Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007; 57(2):105–11. - PubMed
-
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24. - PubMed
-
- Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):626–9. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
